Jeune Aesthetics moves to the Phase 2 trial for fine lines and wrinkles
Biospace - 17-Nov-2022Targeted gene-delivery hold potential in replenishing the skins key protein, to treat fine lines
Join the club for FREE to access the whole archive and other member benefits.
SVP of Marketing at Jeune Aesthetics
Ms. Riharb has over 25 years of senior executive experience with public and private companies in both the medical device and pharmaceutical industries. Her management experience includes global and inline marketing, product management, sales management, business development, strategic planning and operations.
Currently she is the SVP of Marketing for Jeune Aesthetics a biotechnology company leveraging a novel delivery platform for natural skin rejuvenation. She was responsible for commercialization of an aesthetic neurotoxin in her prior role as VP of Marketing for Evolus. As the VP of Development for Allergan, she was instrumental in the successful divestiture of the Allergan Health business. Prior to that role, she served as the Acting COO of EMKinetics, a clinical stage startup with a novel neuromodulation therapy.
Ms. Riharb has held key management positions with True Digital Surgery, Evolus/ALPHAEON, BAROnova, Allergan/INAMED/McGhan Medical, Computer Motion and Circon Corp. She developed and launched the first national consumer medical device commercial to run on all three major networks. The commercial for the LAP-BAND System won the Direct to Consumer National Advertising Award for Best Medical Device and increased unaided awareness by 30% and sales by 90%. Ms. Riharb was also instrumental in the commercialization of the first surgical robots and voice-activated operating rooms.
See also: Jeune Aesthetics (Jeune) - A Gene-Based Aesthetics Company
Details last updated 16-Mar-2023
Targeted gene-delivery hold potential in replenishing the skins key protein, to treat fine lines